Robotic rEhabilitation sCenario fOr patieNts With NeglECT
Launched by FONDAZIONE DON CARLO GNOCCHI ONLUS · Mar 21, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new rehabilitation program for patients who have had a stroke and are experiencing challenges with their upper limbs and attention. Specifically, it aims to test a virtual reality scenario designed to help improve motor skills and cognitive focus in individuals who have right-sided strokes, leading to left-sided weakness and inattention. Participants will take part in 13 rehabilitation sessions, each lasting 45 minutes, where they will use this new virtual reality scenario to help them recover.
To be eligible for this trial, participants must have had a right-sided stroke, show signs of hemi-inattention (difficulty noticing things on one side), and have weakness in their left arm. They also need to be able to sit up independently and provide written consent to join the study. Throughout the trial, researchers will assess how well the new program works and how participants feel about using it. This is an exciting opportunity for those looking to improve their recovery after a stroke using innovative technology!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presence of a diagnosis of right hemispheric stroke
- • Presence of a diagnosis of hemi-inattention (Apple test)
- • Presence of left hemiplegia (Fugl-Meyer Assessment Upper Limb ≤58)
- • Adjusted Montreal Cognitive Assessment \<20
- • Written informed consent
- Exclusion Criteria:
- • Presence of cognitive decline prior to the event
- • Presence of previous stroke events
- • Presence of osteoarticular rigidity (e.g., ankylosis, functional limitations with traumatic or degenerative origin) or spasticity in the affected upper limb (Modified Ashworth Scale ≥3 on shoulder, elbow, or wrist)
- • Inability to maintain a sitting position
- • Presence of severe visual disabilities
- • Recent injection of botulinum toxin in the upper limb or planned injection of botulinum toxin during the study period
- • Orthopaedic, neurological, or psychiatric disorders that could interfere with the study procedures and motor or cognitive assessments
- • Unstable fractures of the upper limb
- • Severe osteoporosis
- • Skin lesions on the upper limb
About Fondazione Don Carlo Gnocchi Onlus
Fondazione Don Carlo Gnocchi Onlus is a distinguished non-profit organization dedicated to advancing healthcare and rehabilitation services for individuals with disabilities and chronic illnesses. Established in honor of the legacy of Don Carlo Gnocchi, the foundation focuses on integrating scientific research with clinical practice, striving to enhance the quality of life for patients through innovative therapies and comprehensive care programs. With a commitment to excellence, the foundation actively engages in clinical trials and research initiatives aimed at improving treatment outcomes and fostering a deeper understanding of rehabilitation methodologies. Its collaborative approach brings together healthcare professionals, researchers, and community stakeholders to promote well-being and support patient-centric solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Firenze, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported